|

Brigatinib Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: ALUNBRIG, Alunbrig, Alunbrig Tablets

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • University Health Network, Toronto1
  • Takeda1
  • Scott R. Plotkin, MD, PhD1
  • Princess Maxima Center for Pediatric Oncology1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

Other4 trials

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Phase 1/2
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Using Tumor Models to Determine Treatments
Phase 2

Los Angeles, California1 trial

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

UCLA Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.